| Financial Year |
March 31 2023 |
| Monetary Funds |
306,858,286.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,121,791.73 |
| Advances to Suppliers |
35,090,074.91 |
| Other Receivables |
248,931,787.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,717,343,277.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
617,487,370.39 |
| Total Current Assets |
13,926,832,589.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
436,580,306.59 |
| Investment Properties |
1,282,943,465.79 |
| Fixed Assetes |
31,155,825.11 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,170,317.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,460,804.78 |
| Deferred Income Tax Assets |
1,484,323.36 |
| Other Non-Current Assets |
47,713,766.57 |
| Sub-Total of Non-Current Assets |
1,814,025,924.32 |
| Total Assets |
15,740,858,513.68 |
| Short-Term Loans |
501,393,823.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,945,851,393.99 |
| Accounts Received In Advance |
154,833.23 |
| Employee Compensation Payable |
11,606,634.75 |
| Taxes Payable |
292,854,298.61 |
| Interest Payable |
188,479,569.00 |
| Dividend Payable |
27,399,349.83 |
| Other payables |
4,091,592,665.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,326,551,250.00 |
| Other Current Liabilities |
39,615,370.54 |
| Sub-Total of Current Liabilities |
9,744,785,654.35 |
| Long-term Loans |
4,582,839,100.00 |
| Bonds Payable |
746,231,909.81 |
| Long-Term Accounts Payable |
17,730,833.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,155,747.96 |
| Deferred Income Tax Liabilities |
1,815,734.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,357,773,325.60 |
| Total Liabilities |
15,102,558,979.95 |
| Paid-In Capital(Or Share Stock) |
1,105,700,000.00 |
| Capital Surplus |
2,400,709,733.27 |
| Surplus Reserve |
304,265,165.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,756,545,959.08 |
| Minority Stockholder's Interest |
584,670,594.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,628,939.56 |
| Owner's Equity（Stockholder's Equity） |
638,299,533.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,740,858,513.68 |
